Avacta Group PLC (AVCT)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
62.00p
Buy
64.00p
-2.50p (-3.85%)
Prices updated at 19 Dec 2025, 16:41 GMT
| Prices minimum 15 mins delay
Prices in GBX
Avacta Group PLC is a United Kingdom based company, which caters to the healthcare sector. It develops medical diagnostic products such as reagents and arrays which are helpful in drug discovery.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 3m | 113,000 | |
| 3m | 113,000 | |
| -22m | -32m | |
| -771.76 | -28,151.33 | |
| -33m | -53m | |
| -15m | -18m | |
| Sales, General and administrative | 8m | 12m |
| Interest expenses | 14m | 10m |
| Provision for income taxes | -2m | 444,000 |
| Operating expenses | 25m | 32m |
| Income before taxes | -31m | -29m |
| Net income available to common shareholders | -33m | -53m |
| -0.0915 | -0.1534 | |
| Net interest income | -14m | -9m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -0.0915 | -0.1534 |
| Free cash flow per share | -0.059 | -0.0691 |
| Book value/share | 0.0808 | 0.1314 |
| Debt equity ratio | 0.339289 | 0.159681 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 28m | 40m |
| Current liabilities | 45m | 37m |
| Total capital | 22m | 9m |
| Total debt | 23m | 23m |
| Total equity | 22m | 9m |
| Total non current liabilities | - | - |
| Loans | - | - |
| Total assets | 73m | 48m |
| Total liabilities | - | - |
| Cash and cash equivalents | 17m | 13m |
| Common stock | 281m | 367m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 42m | 17m |
| Cash dividends paid | - | - |
| -16m | -24m | |
| Investments (gains) losses | -9m | -1m |
| 17m | 18m | |
| Net income | - | - |
| -15m | -24m | |
| -1m | -339,000 |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
